Pei Hua Lee

Dr. Pei Hua Lee


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in medRxiv
Verified
Preprint
Open access
PDF file
PCPo Ying Chia
Po Ying Chia
KCKristen Kelli Coleman
Kristen Kelli Coleman
YTYian Kim Tan
Yian Kim Tan
SOSean Wei Xiang Ong
Sean Wei Xiang Ong
MGMarcus Gum
Marcus Gum
KMKalisvar Marimuthu
Kalisvar Marimuthu
Understanding the particle size distribution in the air and patterns of environmental contamination of SARS-CoV-2 is essential for infection prevention policies. We aimed to detect SARS-CoV-2 surface and air contamination and study associated patient-level factors. 245 surface samples were collected from 30 airborne infection isolation rooms of COVID-19 patients, and air sampling was conducted in 3 rooms. Air sampling detected SARS-CoV-2 PCR-positive particles of sizes >4 µm and 1-4 µm in two rooms, which warrants further study of the airborne transmission potential of SARS-CoV-2. 56.7% of rooms had at least one environmental surface contaminated. High touch surface contamination was shown in ten (66.7%) out of 15 patients in the first week of illness, and three (20%) beyond the first week of illness (p = 0.010).

1 January 2020 in Clinical & Translational Immunology
Verified
Journal Article
Open access
PDF file
PLPei Hua Lee
Pei Hua Lee
WTWoo Chiao Tay
Woo Chiao Tay
SSStephanie Sutjipto
Stephanie Sutjipto
SFSiew‐Wai Fong
Siew‐Wai Fong
SOSean Wei Xiang Ong
Sean Wei Xiang Ong
TLTau Hong Lee
Tau Hong Lee
Objectives: A wide range of duration of viral RNA shedding in patients infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) has been observed. We aimed to investigate factors associated with prolonged and intermittent viral RNA shedding in a retrospective cohort of symptomatic COVID‐19 patients.Methods: Demographic, clinical and laboratory data from hospitalised COVID‐19 patients from a single centre with two consecutive negative respiratory reverse transcription‐polymerase chain reaction (RT‐PCR) results were extracted from electronic medical records. Kaplan–Meier survival curve analysis was used to assess the effect of clinical characteristics on the duration and pattern of shedding. Plasma levels of immune mediators were measured using Luminex multiplex microbead‐based immunoassay.Results: There were 201 symptomatic patients included. Median age was 49 years (interquartile range 16–61), and 52.2% were male. Median RNA shedding was 14 days (IQR 9–18). Intermittent shedding was observed in 77 (38.3%). We did not identify any factor associated with prolonged or intermittent viral RNA shedding. Duration of shedding was inversely correlated with plasma levels of T‐cell cytokines IL‐1β and IL‐17A at the initial phase of infection, and patients had lower levels of pro‐inflammatory cytokines during intermittent shedding.Conclusions: Less active T‐cell responses at the initial phase of infection were associated with prolonged viral RNA shedding, suggesting that early immune responses are beneficial to control viral load and prevent viral RNA shedding. Intermittent shedding is common and may explain re‐detection of viral RNA in recovered patients.

5 March 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
SOSean Wei Xiang Ong
Sean Wei Xiang Ong
DRDongdong Ren
Dongdong Ren
PLPei Hua Lee
Pei Hua Lee
SSStephanie Sutjipto
Stephanie Sutjipto
CDChristopher Dugan
Christopher Dugan
DLDavid C. Lye
David C. Lye
Data on use of monoclonal antibodies (mAbs) in hospitalized patients are limited. In this cross-sectional study, we evaluated the use of mAbs for early treatment of unvaccinated hospitalized patients with mild-to-moderate COVID-19. All inpatients at our center were screened on 27 October 2021. Primary outcome was in-hospital deterioration as defined by a composite of oxygen requirement, intensive care unit (ICU) admission, or mortality within 28 days of admission. Ninety-four out of 410 COVID-19 inpatients were included in the final analysis, of whom 19 (20.2%) received early treatment with sotrovimab. The median age was 73 years (IQR 61–83), and 35 (37.2%) were female. Although the treatment group was significantly older and had more comorbidities, there was a lower proportion of progression to oxygen requirement (31.6% vs. 54.7%), ICU admission (10.5% vs. 24.0%), or mortality (5.3% vs. 13.3%). Kaplan–Meier curves showed a significant difference in time to in-hospital deterioration (log-rank test, p = 0.043). Cox proportional hazards model for in-hospital deterioration showed that sotrovimab treatment was protective (hazard ratio, 0.41; 95% CI, 0.17–0.99; p = 0.047) after adjustment for baseline ISARIC deterioration score. Our findings support the use of sotrovimab for early treatment in hospitalized patients with mild-to-moderate COVID-19 at a high risk of disease progression.

25 June 2020 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
DBDarius L L Beh
Darius L L Beh
DNDorothy H L Ng
Dorothy H L Ng
SOSean Wei Xiang Ong
Sean Wei Xiang Ong
SSStephanie Sutjipto
Stephanie Sutjipto
PLPei Hua Lee
Pei Hua Lee
SASophia Archuleta
Sophia Archuleta
The COVID-19 pandemic has taken over the world at an unprecedented scale. As Infectious Diseases fellows, this has come straight into the heart of our specialty and created a unique impact on our training progress and perspective. Here, we reflect on our early experiences during the first three months of battling COVID-19 in Singapore and glean some lessons for this pandemic and beyond.

27 March 2025 in Annals of the Academy of Medicine, Singapore
Verified
Journal Article
Open access
PLPei Hua Lee
Pei Hua Lee
JLJustin Y Lim
Justin Y Lim
PKP Arun Kumar
P Arun Kumar
ZTZhi Hui Tan
Zhi Hui Tan
RTRayen Bing Hui Tan
Rayen Bing Hui Tan
CWChen Seong Wong
Chen Seong Wong
Introduction: Although pre-exposure prophylaxis (PrEP) has been available in Singapore since 2016, its uptake among gay, bisexual and other men-who-have-sex-with-men (GBMSM) is low. The iPARTY study was established to evaluate the acceptability and feasibility of PrEP and a PrEP teleconsultation service for young GBMSM aged 18 to 29 years. Method: A total of 53 young GBMSM were enrolled in the iPARTY study. They had a total of 5 in-person consultations and teleconsultations, at 12-week intervals. Laboratory tests and quarterly baseline surveys were performed to assess PrEP adherence, sexual behaviour, and incidence of human immunodeficiency virus (HIV) and other sexually transmitted infections (STIs). Results: Thirty-five participants completed the entire 12-month follow-up. Most participants had positive experiences with PrEP teleconsultations. There was a statistically significant fall in participants’ aggregate Patient Health Questionnaire-9 scores throughout the study. Self-reported PrEP adherence decreased over the course of the study, denoting improved mental health. Although self-reported condom use for anal intercourse and participants’ risk perception of HIV decreased after PrEP adoption, there was no statistically significant increase in STI incidence. Conclusion: This pilot project has shown that PrEP services provide an opportunity for YMSM to access sexual health testing, treatment and counselling, and may even have tangible benefits on the mental health of this population. Teleconsultation is shown to be a suitable platform for the delivery of such services. Collaborative initiatives are crucial to further enhance the affordability and accessibility of PrEP in Singapore, and to improve patient adherence.

12 March 2021 in Singapore Medical Journal
Verified
Journal Article
Open access
PLPei Hua Lee
Pei Hua Lee
HTHui Ling Tan
Hui Ling Tan
YCYew Woon Chia
Yew Woon Chia
LLLi Min Ling
Li Min Ling